<DOC>
	<DOC>NCT02051764</DOC>
	<brief_summary>This study will evaluate the imaging characteristics of 18F-AV-1451 in subjects with a previous 18F-AV-1451 scan in order to assess the rate of change of tau deposition over time.</brief_summary>
	<brief_title>Imaging Characteristics of a Follow-up 18F-AV-1451 Scan</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Have a previous 18FAV1451 brain scan Can tolerate up to two Positron Emission Tomography (PET) imaging sessions and a Magnetic Resonance Imaging (MRI) scan Ability to provide informed consent Current clinically significant psychiatric disease Are claustrophobic Current clinically significant cardiovascular disease or ECG abnormalities, or additional risk factors for Torsades de Pointes Current clinically significant infectious disease, endocrine or metabolic disease, pulmonary, renal or hepatic impairment, or cancer Females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception Have had a nonstudy related radiopharmaceutical imaging or treatment procedure within 7 days prior to the study imaging session</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>